/INFU

INFU Stock - InfuSystem Holdings, Inc.

Q: What is the analyst price target for INFU?

Analyst price target information is not currently available for INFU.

Q: What is INFU's market cap?

Market capitalization information is not currently available for INFU.

Healthcare|Medical - Instruments & Supplies|AMEX

$9.20-3.36%

$0.32 (-3.36%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+52.2%upside

Target: $14.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for INFU

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.71

52W High$11.04

52W Low$4.61

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$134.86M	$125.78M	$109.91M	$102.38M	$97.39M
Gross Profit	$70.40M	$63.11M	$60.56M	$58.54M	$58.76M
Gross Margin	52.2%	50.2%	55.1%	57.2%	60.3%
Operating Income	$6.89M	$4.09M	$1.65M	$2.82M	$8.83M
Net Income	$2.35M	$872,000	$18,000	$1.42M	$17.33M
Net Margin	1.7%	0.7%	0.0%	1.4%	17.8%
EPS	$0.11	$0.04	$0.00	$0.07	$0.86

Company Overview

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

100%

Hold / Neutral

Sell / Underperform

Analyst Consensus🟢 Bullish

3 Bullish0 Neutral/Bearish

Price Targets

$13

Average Target

↑ 44.9% Upside

Now

$12

Low

$13

Average

$15

High

Based on 3 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
September 22nd 2025	Lake Street	Resumed	Buy	$15
July 22nd 2025	Roth Capital	Initiation	Buy	$12
September 26th 2024	B. Riley Securities	Initiation	Buy	$13

Earnings History & Surprises

INFU

Beat Rate

39%

Last 18 quarters

Avg Surprise

+6.5%

EPS vs Estimate

Beats / Misses

7/11

Last 12 quarters

Latest EPS

$0.11

Q4 2025

EPS Surprise History

Q1 24

-0.6%

$0.00vs$0.00

Q2 24

-350.0%

$-0.05vs$-0.01

Q3 24

-18.2%

$0.03vs$0.04

Q4 24

+33.3%

$0.08vs$0.06

Q1 25

-50.0%

$0.04vs$0.08

Q2 25

+66.7%

$-0.01vs$-0.03

Q3 25

+300.0%

$0.12vs$0.03

Q4 25

+37.5%

$0.11vs$0.08

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 6, 2026	—	—	—	—
Q1 2026	Mar 3, 2026	$0.07	—	—	—
Q4 2025	Nov 4, 2025	$0.08	$0.11	+37.5%	✓ BEAT
Q3 2025	Aug 5, 2025	$0.03	$0.12	+300.0%	✓ BEAT
Q2 2025	May 8, 2025	$-0.03	$-0.01	+66.7%	✓ BEAT
Q1 2025	Mar 4, 2025	$0.08	$0.04	-50.0%	✗ MISS
Q4 2024	Nov 7, 2024	$0.06	$0.08	+33.3%	✓ BEAT
Q3 2024	Aug 8, 2024	$0.04	$0.03	-18.2%	✗ MISS
Q2 2024	May 9, 2024	$-0.01	$-0.05	-350.0%	✗ MISS
Q1 2024	Mar 14, 2024	$0.00	$0.00	-0.6%	✗ MISS
Q4 2023	Nov 7, 2023	$0.03	$0.03	+20.0%	✓ BEAT
Q3 2023	Aug 3, 2023	$0.00	$0.02	+500.6%	✓ BEAT
Q2 2023	May 4, 2023	$-0.01	$-0.02	-199.9%	✗ MISS
Q1 2023	Mar 15, 2023	$0.04	$0.01	-76.9%	✗ MISS
Q4 2022	Nov 8, 2022	$0.01	$0.02	+199.9%	✓ BEAT
Q3 2022	Aug 4, 2022	$-0.01	$-0.01	-49.9%	✗ MISS
Q2 2022	May 5, 2022	$-0.01	$-0.02	-40.0%	✗ MISS
Q1 2022	Feb 10, 2022	$0.07	$0.02	-71.4%	✗ MISS
Q4 2021	Nov 15, 2021	$0.06	$-0.02	-133.3%	✗ MISS
Q3 2021	Aug 12, 2021	$0.08	$0.04	-50.0%	✗ MISS

Frequently Asked Questions about INFU

What is INFU's current stock price?

InfuSystem Holdings, Inc. (INFU) is currently trading at $9.20 per share. The stock has moved -3.36% today.

What is the analyst price target for INFU?

The average analyst price target for INFU is $14.00, based on 1 analyst.

What sector is InfuSystem Holdings, Inc. in?

InfuSystem Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the AMEX exchange.

What is INFU's market cap?

InfuSystem Holdings, Inc. has a market capitalization of $0.19 billion, making it a small-cap company.

Does INFU pay dividends?

No, InfuSystem Holdings, Inc. does not currently pay a dividend to shareholders.